Solstein Capital’s Teladoc Health TDOC Stock Holding History

Solstein Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-600	Closed	-$115K	–	228
2020 Q2	$115K	Buy	+600	New	+$105K	0.27%	69

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Solstein Capital's TDOC Position: Q3 2020 in Review

Solstein Capital sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 600 shares — an estimated $115K sold.

Solstein Capital first reported a position in TDOC in Q2 2020 and held it in 1 quarter. The position peaked at $115K in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

Solstein Capital reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
Solstein Capital sold 600 Teladoc Health shares in Q3 2020, an estimated $115K.
Solstein Capital first reported a position in Teladoc Health in Q2 2020 and held it in 1 quarter.
Solstein Capital's Teladoc Health position peaked at $115K in Q2 2020.
743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Solstein Capital's 13F filing for Q3 2020, filed 12 Nov 2020.